Comparative performance of two methods that assess the quality of international normalized ratio measures

被引:1
|
作者
Shermock, Kenneth M. [1 ]
Tandon, Sangeeta [2 ]
Sorgen, Patrick J. [3 ]
Lavallee, Danielle C. [4 ]
Clarke, William [5 ]
Streiff, Michael B. [6 ]
机构
[1] Johns Hopkins Med Inst, Ctr Pharmaceut Outcomes, Baltimore, MD 21205 USA
[2] Univ Iowa, Coll Pharm, Iowa City, IA 52242 USA
[3] Purdue Univ, Coll Pharm, W Lafayette, IN 47907 USA
[4] Ctr Med Technol Policy, Baltimore, MD USA
[5] Johns Hopkins Sch Med, Dept Pathol, Div Clin Chem, Baltimore, MD USA
[6] Johns Hopkins Sch Med, Div Hematol, Dept Med, Baltimore, MD USA
关键词
Coagulation monitoring; Point-of-care testing; POCT; PT INR; Healthcare quality assurance; AGREEMENT;
D O I
10.1016/j.clinbiochem.2012.01.032
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objectives: Two methods, Petersen's error grid analysis and Shermock's method to detect clinically important differences, were recently developed to advance the assessment of analytic performance of point-of-care INR devices. Both methods predict when alternate INR measures lead to different clinical decisions. Our goal was to compare their performance characteristics. Design and methods: Performance characteristics were assessed by comparing the models' predictions to clinical decisions that were directly measured in a previous experiment. Results: Shermock's method (82% of predictions correct) demonstrated superior predictive performance compared with the error grid analysis (75% of predictions correct, p = 0.008). Shermock's method was particularly superior at identifying the clinical decisions that actually disagreed (79% for Shermock's method vs. 47% for error grid). Consequently, Shermock's method was superior at identifying a POC device with poor performance (79% accuracy vs. 70%, p = 0.006). Conclusion: Shermock's method had superior performance characteristics and should be integrated into analytic strategies to assess POC INR devices. (C) 2012 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:530 / 534
页数:5
相关论文
共 50 条
  • [21] THE INTERNATIONAL NORMALIZED RATIO (INR) FOR MONITORING WARFARIN THERAPY - RELIABILITY AND RELATION TO OTHER MONITORING METHODS
    LE, DT
    WEIBERT, RT
    SEVILLA, BK
    DONNELLY, KJ
    RAPAPORT, SI
    ANNALS OF INTERNAL MEDICINE, 1994, 120 (07) : 552 - 558
  • [22] COMBINING TRACK QUALITY AND PERFORMANCE MEASURES TO ASSESS TRACK MAINTENANCE REQUIREMENTS
    Roghani, Alireza
    Macciotta, Renato
    Hendry, Michael
    PROCEEDINGS OF THE ASME JOINT RAIL CONFERENCE, 2015, 2015,
  • [23] Quality of life (QoL) and International Normalized Ratio (INR) control of patients attending anticoagulation clinics
    Hasan, S. S.
    Teh, K. M.
    Ahmed, S. I.
    Chong, D. W. K.
    Ong, H. C.
    Naina, B.
    PUBLIC HEALTH, 2015, 129 (07) : 954 - 962
  • [24] Establishing an external quality assessment scheme for point-of-care international normalized ratio in Thailand
    Tientadakul, P.
    Chuntarut, A.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2015, 37 (04) : 509 - 514
  • [25] Alpha decay and Sharpe ratio: Two measures of investor performance
    Guo, Ming
    Ou-Yang, Hui
    ECONOMIC MODELLING, 2021, 104
  • [26] External quality assessment of point-of-care International Normalized Ratio (INR) testing in Europe
    Stavelin, Anne
    Meijer, Piet
    Kitchen, Dianne
    Sandberg, Sverre
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2012, 50 (01) : 81 - 88
  • [27] Quality assessment of CoaguChek point-of-care international normalized ratio monitors: A note of caution
    Kitchen, Steve
    Kitchen, Dianne
    Jennings, Ian
    Woods, Tim
    Walker, Isobel
    CLINICAL CHEMISTRY, 2007, 53 (08) : 1555 - 1556
  • [28] International normalized ratio discrepancy in the oral anticoagulant therapy spanish external quality assessment scheme
    Gutierrez, Gabriela
    Perez, Aranzazu
    Vacas, Marta
    Tassies, Dolors
    Reverter, Joan Carles
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2007, 29 : 71 - 72
  • [29] FAILURE OF THE BLAND-ALTMAN METHOD TO IDENTIFY CLINICALLY IMPORTANT DISAGREEMENT BETWEEN MEASURES OF THE INTERNATIONAL NORMALIZED RATIO
    Shermock, K. M.
    VALUE IN HEALTH, 2010, 13 (03) : A179 - A179
  • [30] INTERNATIONAL NORMALIZED RATIO - IS THERE STANDARDIZATION OF REPORTING FOR THE PROTHROMBIN TIME IN THE PROVINCE OF ONTARIO? A RETROSPECTIVE ANALYSIS OF PERFORMANCE
    Moffat, Karen A.
    Selby, Rita
    Keeney, Michael
    Raby, Anne
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2012, 34 : 163 - 164